PGD conditions
This table shows all PGD conditions currently approved and awaiting consideration by the HFEA.
Please note that we are updating this database, and some approved conditions may not be displayed. If you are unsure if a condition has been approved or not, please contact pgd@hfea.gov.uk.
Condition name | Status | OMIM number | Documents |
---|---|---|---|
Progressive External Opthalmoplegia with Mitochondrial DNA Deletions, Autosomal Dominant 3 (PEOA3) | approved | 609286 | |
Progressive Familial Intrahepatic Cholestasis Type 1 (PFIC1) | approved | 211600 | |
Prolidase Deficiency | approved | 170100 | |
Propionic Acidemia | approved | 606054 | |
Pseudoachondroplasia | approved | 177170 | |
Pseudohypoparathyroidism (PHP1a) | approved | 103580 | |
Pseudo-TORCH syndrome-type 1 | approved | 251290 | |
Pseudo-TORCH syndrome-type 2 | approved | 617397 | |
Pseudovaginal Perineoscrotal Hypospadias due to 5-Alpha-Reductase Deficiency (insofar as that condition affects males, with simultaneous sex determination) | approved | 264600 | |
Pyogenic Arthritis, Pyoderma Gangrenosum and Acne Syndrome (PAPA) | approved | 604416 | |
Pyrodoxine-dependent seizures (EPD) | approved | 266100 | |
Pyruvate dehydrogenase E1-alpha deficiency X-linked | approved | 312170 | |
Pyruvate Dehydrogenase E1-beta Deficiency | approved | 614111 | |
Pyruvate Dehydrogenase, Alpha-1 (PDHA1) | approved | 312170 | |
Radioulnar synostosis with amegakaryocytic thrombocytopenia type 1 and type 2 (RUSAT) | awaiting approval | 605432 | |
Rapp-Hodgkin Syndrome (RHS) | approved | 129400 | |
Recurrent Digynic Triploidy | approved | ||
Recurrent hydatidiform mole (HYDM1) | approved | 231090 | |
Recurrent infections with encephalopathy, hepatic dysfunction and cardiovascular malformations (FADD deficiency) | approved | 613759 | |
Renal cell carcinoma, papillary, 1 (RCCP1) | approved | 605074 | |